Rhiannon Nicole Hardwick, PhD, DABT is currently a Scientific Associate Director in Discovery Toxicology at Bristol Myers Squibb, San Diego, where she serves as project representative on discovery phase programs and leads an in vitro toxicology lab. Previously as a Senior Scientist in Translational Safety Sciences at Theravance Biopharma, Dr. Hardwick served as a project toxicologist on small molecule discovery and development phase programs. She also served as an internal working group leader focused on expanding knowledge and implementation of 3D tissues and microphysiological systems in the drug development process. Rhiannon remains invested in the qualification of complex in vitro models, including microphysiological systems, for toxicology applications and serves as the Vice Chair-Elect to the IQ Consortium Microphysiological Systems Affiliate.
Dr. Hardwick has been an active member of SOT since 2009, is a Diplomate of the American Board of Toxicology, a member of the American College of Toxicology, and has served on an organizing committee for the ToxForum. She has also been involved in the Cellular and Molecular Mechanisms of Toxicity Gordon Research Conference and Seminar since 2015. Dr. Hardwick has been a regular guest lecturer in the General and Systems Toxicology and Drug Metabolism and Disposition Courses in the College of Pharmacy at the University of Arizona since 2017. She has also been a guest lecturer for San Diego State University, serves on the Washington State University Industry Advisory Board, and has also organized and participated in several career development webinars and mentoring events for SOT. Through each of these various activities, Dr. Hardwick has and continues to seek out opportunities for mentoring and honoring the achievements of younger scientists.